In the Superior Court of New Jersey the Honorable Carol E. Higbee has ordered the defendant, Johnson & Johnson’s Ethicon Inc., must disclose its communications with the FDA regarding the safety of its Gynecare line of transvaginal mesh products.
Communications Reviewed for Evidence of J&J Knowledge Dangerous and Defective
Plaintiff’s attorneys will be searching for additional evidence that Johnson & Johnson’s Ethicon Inc. knew the devices implanted in women were dangerous and defective. Attorneys hope to show that the Company continued to sell the devices though they knew of the dangers. The FDA demanded Ethicon remove transvaginal mesh from the market for implant in 2007 while it determined whether the Gynecare Prolift was safe. Ethicon refused.